InsiderSignal.AI

InsiderSignal.ai

IRTC - Irhythm Holdings, Inc.

Insider Sale by Blackford Quentin S. (Pres, CEO)

1 Month
After Trade
Before Trade

Loading data...

Trade Summary

2 days ago, Blackford Quentin S., serving as Pres, CEO at Irhythm Holdings, Inc. (IRTC), sold 25,540 shares at $135.42 per share, for a total transaction value of $3,458,599.00. Following this transaction, Blackford Quentin S. now holds 186,126 shares of IRTC.

This sale represents a 12.00% decrease in Blackford Quentin S.'s stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Wednesday, February 25, 2026 and publicly disclosed via SEC Form 4 filing on Thursday, February 26, 2026, 1 day after the trade was made.

Irhythm Holdings, Inc. operates in the HEALTHCARE sector, specifically within the MEDICAL DEVICES industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.

Blackford Quentin S.

Pres, CEO

Quentin S. Blackford is the President and Chief Executive Officer of iRhythm Technologies, Inc. (NASDAQ: IRTC), a digital healthcare company specializing in cardiac arrhythmia detection through wearable biosensors like the Zio device.[[1]](https://investors.irhythmtech.com/news/news-details/2021/iRhythm-Technologies-Names-Quentin-Blackford-President-and-Chief-Executive-Officer/default.aspx)[[4]](https://investors.irhythmtech.com/governance/board-of-directors/person-details/default.aspx?ItemId=27466c57-64f8-4000-bc9c-856f24be825d)[[6]](https://investors.irhythmtech.com/governance/executive-management/default.aspx) Appointed to this dual role and the Board of Directors effective October 4, 2021, Blackford has led the company through growth phases, focusing on innovation, market expansion, and profitability in arrhythmia diagnostics.[[1]](https://investors.irhythmtech.com/news/news-details/2021/iRhythm-Technologies-Names-Quentin-Blackford-President-and-Chief-Executive-Officer/default.aspx)[[2]](https://www.fiercebiotech.com/medtech/irhythm-gets-back-beat-tapping-former-dexcom-exec-blackford-as-ceo)[[4]](https://investors.irhythmtech.com/governance/board-of-directors/person-details/default.aspx?ItemId=27466c57-64f8-4000-bc9c-856f24be825d)[[5]](https://www.youtube.com/watch?v=QcA9U2Y1zlY) Blackford brings over 20 years of experience in medical devices and digital health, most recently as Chief Operating Officer at Dexcom, Inc. (2019–2021), where he oversaw global operations, strategy, and market expansion after joining as CFO in 2017.[[1]](https://investors.irhythmtech.com/news/news-details/2021/iRhythm-Technologies-Names-Quentin-Blackford-President-and-Chief-Executive-Officer/default.aspx)[[2]](https://www.fiercebiotech.com/medtech/irhythm-gets-back-beat-tapping-former-dexcom-exec-blackford-as-ceo)[[4]](https://investors.irhythmtech.com/governance/board-of-directors/person-details/default.aspx?ItemId=27466c57-64f8-4000-bc9c-856f24be825d) Previously, he was Executive Vice President, CFO, Head of Strategy, and Corporate Integrity at NuVasive from 2009, driving acquisitions, product portfolio growth, and geographic expansion.[[1]](https://investors.irhythmtech.com/news/news-details/2021/iRhythm-Technologies-Names-Quentin-Blackford-President-and-Chief-Executive-Officer/default.aspx)[[2]](https://www.fiercebiotech.com/medtech/irhythm-gets-back-beat-tapping-former-dexcom-exec-blackford-as-ceo) Earlier roles include leading Global Financial Planning & Analysis at Zimmer Holdings, Inc., and Director of Finance/Controller for its Dental Division.[[1]](https://investors.irhythmtech.com/news/news-details/2021/iRhythm-Technologies-Names-Quentin-Blackford-President-and-Chief-Executive-Officer/default.aspx) He serves as an independent director at Alphatec Holdings, Inc. (since 2017) and Paragon 28, Inc. (since 2022).[[4]](https://investors.irhythmtech.com/governance/board-of-directors/person-details/default.aspx?ItemId=27466c57-64f8-4000-bc9c-856f24be825d) A Certified Public Accountant (inactive), Blackford holds dual Bachelor of Science degrees in Accounting and Business Administration from Grace College.[[1]](https://investors.irhythmtech.com/news/news-details/2021/iRhythm-Technologies-Names-Quentin-Blackford-President-and-Chief-Executive-Officer/default.aspx)[[4]](https://investors.irhythmtech.com/governance/board-of-directors/person-details/default.aspx?ItemId=27466c57-64f8-4000-bc9c-856f24be825d)

View full insider profile →

Trade Price

$135.42

Quantity

25,540

Total Value

$3,458,599.00

Shares Owned

186,126

Trade Date

Wednesday, February 25, 2026

2 days ago

SEC Filing Date

Thursday, February 26, 2026

Filed 1 day after trade

HEALTHCAREMEDICAL DEVICES

About Irhythm Holdings, Inc.

Company Overview

No company information available
View news mentioning IRTC

💬 Want Deeper Insight?

Use our AI assistant to ask questions about this trade, the insider, or the company.

Chat with AI

Share this trade

https://insidersignal.ai/trade/4325653

🚀 Track Insider Trades in Real-Time

Create a free account to access our full database of insider trades, AI-powered analysis, price alerts, and discover what corporate executives are buying and selling.

Create Free AccountLearn More

✓ Free forever plan available  •  ✓ No credit card required  •  ✓ Cancel anytime